Catalysts for Dupixent
33 tracked
Apr 30, 2026
phase 2 completion
Brigham and Women's Hospital โ dupilumab (Phase II Trial Completion)
dupilumab
โ
Apr 27, 2026
pdufa
Regeneron Pharmaceuticals Inc โ dupilumab (PDUFA)
dupilumab
โ
Apr 16, 2026
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Feb 23, 2026
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 18, 2025
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Apr 17, 2025
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Apr 16, 2025
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Sep 27, 2024
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Sep 12, 2024
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Apr 12, 2024
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jan 25, 2024
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jan 12, 2024
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Sep 29, 2023
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jul 14, 2023
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Oct 17, 2022
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Sep 28, 2022
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 7, 2022
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
May 20, 2022
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Dec 22, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Dec 22, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Dec 22, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Oct 20, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Oct 1, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 14, 2021
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 18, 2020
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 18, 2020
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
May 26, 2020
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Jun 26, 2019
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Mar 11, 2019
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ
Oct 19, 2018
approval
DUPIXENT (DUPILUMAB) โ FDA approval
dupilumab
โ